ArticleArthritis research & therapy2016

Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.

Claudio Corallo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.